Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Non Operating Income (2020 - 2025)

Harmony Biosciences Holdings' Non Operating Income history spans 6 years, with the latest figure at -$105000.0 for Q4 2025.

  • For Q4 2025, Non Operating Income fell 165.62% year-over-year to -$105000.0; the TTM value through Dec 2025 reached -$680000.0, down 900.0%, while the annual FY2025 figure was -$680000.0, 900.0% down from the prior year.
  • Non Operating Income for Q4 2025 was -$105000.0 at Harmony Biosciences Holdings, up from -$106000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $193000.0 in Q4 2023 and bottomed at -$276000.0 in Q1 2025.
  • The 5-year median for Non Operating Income is -$2000.0 (2022), against an average of -$21263.2.
  • The largest annual shift saw Non Operating Income skyrocketed 740.0% in 2022 before it tumbled 7150.0% in 2024.
  • A 5-year view of Non Operating Income shows it stood at $31000.0 in 2021, then soared by 135.48% to $73000.0 in 2022, then surged by 164.38% to $193000.0 in 2023, then decreased by 17.1% to $160000.0 in 2024, then plummeted by 165.62% to -$105000.0 in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Non Operating Income are -$105000.0 (Q4 2025), -$106000.0 (Q3 2025), and -$193000.0 (Q2 2025).